EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Involvement of NEK2 and NEK9 in LPS - induced endothelial barrier dysfunction

Nektarios Barabutis, Mohammad S Akhter

Microvascular Research · 2024

DOI: 10.1016/j.mvr.2023.104651 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microvascular Research, 2024. Verfasst von Nektarios Barabutis und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA 71201, USA. Electronic add…. Hauptthemen laut MEDLINE: Endothelial Cells, Lipopolysaccharides. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIGMS NIH HHS, National Institutes of Health, NIGMS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endothelial hyperpermeability is the hallmark of severe lung injury, including acute respiratory distress syndrome. Despite the fact that Never In Mitosis A (NIMA)-related kinase 2 (NEK2) and NEK9 mediate fundamental cellular processes, our knowledge on their role in barrier function is limited. Herein we show that NEK2 and NEK9 inhibition suppresses LPS-induced paracellular hyperpermeability and myosin light chain 2 activation in endothelial cells. Moreover, the expression levels of both kinases were elevated in inflamed mouse lungs. Based on those findings, we raise the possibility that NEK2 and NEK9 may serve as novel therapeutic targets in lung inflammatory disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endothelial CellsLipopolysaccharidesAnimalsMiceEndotheliumLungSignal TransductionNIMA-Related Kinases

Stichwörter der Autor:innen

Barrier integrityInflammationPermeability

Substanzen

LipopolysaccharidesNek9 protein, mouseNIMA-Related KinasesNek2 protein, mouse

Autor:innen und Institutionen

  • School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA 71201, USA. Electronic address: barabutis@ulm.edu.
  • School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA 71201, USA.

Förderung

  • NIGMS NIH HHS
  • National Institutes of Health
  • NIGMS

Zitieren

APA

Barabutis, N., & Akhter, M. S. (2024). Involvement of NEK2 and NEK9 in LPS - induced endothelial barrier dysfunction. Microvascular Research. https://doi.org/10.1016/j.mvr.2023.104651

Vancouver

Barabutis N, Akhter MS. Involvement of NEK2 and NEK9 in LPS - induced endothelial barrier dysfunction. Microvascular Research. 2024. doi:10.1016/j.mvr.2023.104651

BibTeX
@article{Barabutis2024,
  author = {Barabutis, Nektarios and Akhter, Mohammad S},
  title = {Involvement of NEK2 and NEK9 in LPS - induced endothelial barrier dysfunction},
  journal = {Microvascular Research},
  year = {2024},
  doi = {10.1016/j.mvr.2023.104651}
}
Kostenlos starten →